Cannabis Safety & Efficacy
via Science & Technology
Cannabis has gained widespread attention in recent years, and has been used to treat or alleviate symptoms of various diseases and conditions. According to a report by imarc, the global medical cannabis market is expected to reach US $44 billion by 2024, supported by investments in clinical trials and R&D. However, as scientists continue to learn more about cannabinoids and their medicinal effects, there remains no standardized assessment of efficacy for cannabis in clinical diagnostics. Furthermore, the vast variety of pure/hybrid cannabis plants and their growing conditions adds to the complexity of attempts to create such a standardized assessment.
JUNOKANA is reverse-engineering the standardization process by measuring and defining metabolic response due to cannabis use or treatment.
Metabolomics...
-
provides a picture of health
-
can aid in the diagnosis of disease
-
can measure the efficacy of cannabis-based treatment
-
can assess the body's inner response to cannabis use/treatment
-
can characterize each person's biochemical response to different varieties of cannabis (enable personalized medical cannabis treatment)
-
can lead the future of cannabis clinical application and testing to enable better patient care
Specifically designed to guide cannabis-based materials, products, and services into compliance with government regulations for conducting scientific research, including clinical studies performed on behalf of customer companies.
​
-
Cannabis-based materials and products (Producer)
-
Cannabis-based materials and products that are subject to FDA and other government agency compliance regulation​
-
-
Cannabis pharmacologists and dispensaries (Distributor)
-
JUNOKANA Cannabis Consumer Kit helps pharmacologists make safe and medically sound recommendations for cannabis use
-
Safety and Efficacy Testing for the Entire Cannabis Market*
-
cannabis patients and consumers
-
dispensaries and product distributors
-
farms, growers, and product manufacturers
*Disclaimer: JUNOKANA Kit provides information about the state of metabolic pathways in a patient treated with medical cannabis products. It is not a diagnostic test and is not cleared by the US Food and Drug Administration.
